SCHEMBL23721402

SCHEMBL23721402

CC(C)CCC(=O)NC(C=O)CC1CCNC1=O

nearest known ligand 0.50

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ CTSL P07711 1/20 0.45
▸ CTSB P07858 1/20 0.45
▸ CTSS P25774 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30174896 1.00 CTSL (0.45) CTSLCTSBCTSS
SCHEMBL30913965 0.85 CCR2 (0.47) —
SCHEMBL23722564 0.85 — —
SCHEMBL23721439 0.84 — —
SCHEMBL22758567 0.82 — —
SCHEMBL15598678 0.82 — —
SCHEMBL25530819 0.81 NOD1 (0.48) CTSLCTSB
SCHEMBL30222931 0.81 — —
SCHEMBL25006965 0.81 CTSL (0.53) CTSLCTSBCTSS
SCHEMBL30823567 0.81 NOD1 (0.41) CTSLCTSB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4380920-A1 INHIBITORS FOR CORONAVIRUSES Cocrystal Pharma, Inc. (US) 2024-06-12 — — EP disclosed
WO-2023014758-A1 INHIBITORS FOR CORONAVIRUSES COCRYSTAL PHARMA, INC. (US) 2023-02-09 — — WO disclosed
WO-2021151265-A1 PHARMACEUTICAL USE OF ALDEHYDE-BASED COMPOUND 中国科学院上海药物研究所 2021-08-05 — — WO disclosed
Send feedback